Immunotherapy: past, present and future

被引：437

作者：

Waldmann, TA ^{[1
]}

机构：

[1] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

NATURE MEDICINE | 2003年 / 9卷 / 03期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nm0303-269

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Harnessing the immune system to treat chronic infectious diseases or cancer is a major goal of immunotherapy. Among others, impediments to this aim include host failure to identify tumor antigens, tolerance to self and negative immunoregulatory mechanisms. But with recent progress, active and passive immunotherapy are proving themselves as effective therapeutic strategies.

引用

页码：269 / 277

页数：9

共 70 条

[61] DNA immunization induces protective immunity against B-cell lymphoma
Syrengelas, AD
Chen, TT
Levy, R
[J]. NATURE MEDICINE, 1996, 2 (09) : 1038 - 1041
[62] NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
Terabe, M
Matsui, S
Noben-Trauth, N
Chen, HJ
Watson, C
Donaldson, DD
Carbone, DP
Paul, WE
Berzofsky, JA
[J]. NATURE IMMUNOLOGY, 2000, 1 (06) : 515 - 520
[63] WALDMANN TA, 1993, BLOOD, V82, P1701
[64] RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC
WALDMANN, TA
WHITE, JD
CARRASQUILLO, JA
REYNOLDS, JC
PAIK, CH
GANSOW, OA
BRECHBIEL, MW
JAFFE, ES
FLEISHER, TA
GOLDMAN, CK
TOP, LE
BAMFORD, R
ZAKNOEN, S
ROESSLER, E
KASTENSPORTES, C
ENGLAND, R
LITOU, H
JOHNSON, JA
JACKSONWHITE, T
MANNS, A
HANCHARD, B
JUNGHANS, RP
NELSON, DL
[J]. BLOOD, 1995, 86 (11) : 4063 - 4075
[65] MONOCLONAL-ANTIBODIES IN DIAGNOSIS AND THERAPY
WALDMANN, TA
[J]. SCIENCE, 1991, 252 (5013) : 1657 - 1662
[66] The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
Waldmann, TA
Tagaya, Y
[J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 19 - 49
[67] Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy
Waldmann, TA
Dubois, S
Tagaya, Y
[J]. IMMUNITY, 2001, 14 (02) : 105 - 110
[68] Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
Witzig, TE
Gordon, LI
Cabanillas, F
Czuczman, MS
Emmanouilides, C
Joyce, R
Pohlman, BL
Bartlett, NL
Wiseman, GA
Padre, N
Grillo-López, AJ
Multani, P
White, CA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2453 - 2463
[69] Pretargeting radioinimunotherapy of a murine model of adult T-cell leukemia with the α-emitting radionuclide, bismuth 213
Zhang, ML
Yao, ZS
Garmestani, K
Axworthy, DB
Zhang, Z
Mallett, RW
Theodore, LJ
Goldman, CK
Brechbiel, MW
Carrasquillo, JA
Waldmann, TA
[J]. BLOOD, 2002, 100 (01) : 208 - 216
[70] Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15
Zhang, XH
Sun, SQ
Hwang, IK
Tough, DF
Sprent, J
[J]. IMMUNITY, 1998, 8 (05) : 591 - 599

← 1 2 3 4 5 6 7 →